Sii Poland’s Post

Discover how point-of-care AI is effectively being used to streamline care workflows, accelerating time to diagnosis and therapy, and ultimately, improving patient outcomes. Join the live discussion on April 25 here: https://bit.ly/43ND5NN Experts from AstraZeneca, Genentech, IPG Health and Viz.ai share how they are harnessing AI to set new benchmarks for commercial success. #pharmaAI #commercialstrategy #pointofcareAI

Alongside leaders on my Sanofi Market Access team, we are attending the Prime Therapeutics #SpecialtySummit2024 It is great to hear about recent developments and key trends shaping healthcare—especially around AI and its transformative impact. Key takeaways so far: ✅ AI in Healthcare: AI is revolutionizing healthcare by improving patient outcomes, operational efficiency, and streamlining processes. ✅ Specialty Pharmacy Advancements: There's a growing focus on #enhancingaccess to cutting-edge specialty treatments, especially for chronic and complex conditions. ✅Collaboration is Key: Learning from industry leaders, peers, and customers has reinforced that cross-industry collaboration is essential to drive innovation and patient-centered solutions. ✅ Future-Focused Strategies: As healthcare continues to evolve, it’s crucial to analyze recent developments and chart a strategic course for the future. #marketaccess #allinonai Daye Bexley Denise Burgh, MBA Lissa Weldon

Exciting news! I’ll be joining Steven Zelenkofske at SLZ Consulting, LLC and Leonardo Faoro, MD, MBA at Quanta Therapeutics for a panel discussion on #ArtificialIntelligence in clinical development at CMO Summit 360°. Join us as we discuss how we're using AI to better design clinical trials and enhance investigator site selection. If you're attending, stop by booth #25 to see our AI-driven Trial Accelerator™ platform in action. Our platform is designed to help sponsors simulate #clinicaltrials in #clinicaldevelopment with greater precision, insight, and certainty. With global and contextualized data from 108 million patients, 195 countries, and over 4,000 indications, we create Digital Patient Profiles and build #digitaltwins to deliver innovative medicines like Keytruda and Tepmetko. Let's talk about how we can help you achieve your clinical development goals!

Revolutionizing Healthcare: Generative AI powers Disease Prediction and Prevention, Clinical Notes Generation and groundbreaking drug discovery. The future of healthcare starts here! Disease Prediction and Prevention: Leveraging Generative AI to analyze patient data and identify patterns indicative of potential diseases, allowing for early detection and proactive intervention to prevent adverse health outcomes. Clinical Notes Generation: Utilizing Generative AI to automatically generate accurate and detailed clinical notes based on patient interactions, streamlining documentation processes for healthcare providers and improving overall efficiency in healthcare delivery. Drug discovery: Revolutionizing pharmaceutical research with Generative AI, accelerating the discovery of novel drugs and advancing treatment options for various medical conditions. #GenerativeAI #MedicalImaging #PersonalizedMedicine #PrecisionMedicine #HealthTech #DrugDiscovery #AIinHealthcare #InnovativeTreatment #MedicalResearch #FutureofMedicine #involead

𝗔𝗜 𝗮𝗻𝗱 𝗕𝗲𝗵𝗮𝘃𝗶𝗼𝗿𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 - The last pandemic turbo-charged the emerging trend of digital therapeutics (#DTx), highlighting their potential for improved, personalized treatment across conditions. - Digital therapeutics will become more effective and grow in the market by integrating AI and behavioral science insights. - #Pharma and #medtech companies will keep exploring and promoting digital therapeutics to enhance medicine efficacy, access patient data, and bolster brand reputation. Check out the full report: swiy.co/PA1E #digitalhealth #futureofhealth

𝗔𝗜 𝗮𝗻𝗱 𝗕𝗲𝗵𝗮𝘃𝗶𝗼𝗿𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 - The last pandemic turbo-charged the emerging trend of digital therapeutics (#DTx), highlighting their potential for improved, personalized treatment across conditions. - Digital therapeutics will become more effective and grow in the market by integrating AI and behavioral science insights. - #Pharma and #medtech companies will keep exploring and promoting digital therapeutics to enhance medicine efficacy, access patient data, and bolster brand reputation. Check out the full report: swiy.co/PA1E #digitalhealth #futureofhealth

Join Us at HLTH Europe in Amsterdam! Don't miss the opportunity to hear from our expert, Dr. Parvin Moyassari, as she presents insights into Generative AI in the pharmaceutical industry. At HLTH Europe, Dr. Parvin Moyassari will be delivering two must-attend presentations: Generative AI Use Cases in Pharma This presentation dives into real-world use cases that showcase the transformative potential of GenAI in the life sciences value chain. Learn how these advancements are solving complex challenges and opening new avenues for health and healing. Scaling Generative AI Discover the practical applications and impact of GenAI in medical diagnostics, device innovation, patient care, and more. This session will guide you through the successful deployment and scaling of GenAI technologies, illustrating their far-reaching capabilities. Watch Parvin's sneak preview video and get a taste of the insights and innovations she will share at HLTH Europe. If you plan to be at HLTH in Amsterdam, register now to join our presentations: https://bit.ly/3QibjU8 #HLTHEurope #GenerativeAI #PharmaInnovation #HealthcareTransformation #LifeSciences #AIinHealthcare

Uncover how AI-driven predictive imaging is revolutionizing clinical trials. Learn how top sponsors like AstraZeneca and Bayer are utilizing these advanced models to speed up drug development, cut costs, and improve treatment efficacy. Join Felix Baldauf-Lenschen, CEO of Altis Labs, by clicking below:   https://lnkd.in/gka5vn5J Talk time stamp: 42 min - 1 hour 9 min. #ai #imaging #drugdevelopment #clinicaltrails

☀ In July, we have observed that the use of AI is becoming embedded in our everyday lives, including the diagnostic space. From enhancing diagnostic accuracy to accelerating drug discovery, AI-driven technologies are revolutionizing the healthcare landscape. Companies are leveraging AI to streamline workflows, reduce costs, and improve patient outcomes. As AI continues to integrate into the diagnostic sector, we are witnessing unprecedented advancements in personalized medicine, early disease detection, and efficient treatment planning. The future of diagnostics is here, powered by AI, and it's transforming how we understand and treat diseases. 🏃♀️ We saw companies kick off new programs and products; Creative Medical Technology Holdings Inc. (Nasdaq: CELZ) who initiated the development of an AI-driven diagnostic and treatment program for biological and chemical exposure using its iPSC Personalized Medicine Program. Insilico Medicine hosted a product launch event for new AI tools aimed at accelerating drug discovery and sustainability in the pharmaceutical industry. 💸 A couple funding rounds highlighted this; Spotlight Medical with a €6.2 million Seed Funding to enhance cancer treatment strategies with AI-powered prognosis tests. The funding will be used to bring its first prognosis test to the clinic. RetiSpec Inc with a $10 million Series A Financing to advance the commercialization of its AI-driven eye test for early detection of Alzheimer's disease. The funding was led by iGan Partners with participation from strategic investors including Eli Lilly and Company. #AI #HealthcareInnovation #Diagnostics #ArtificialIntelligence #MedicalTechnology #FutureOfHealth #TechInHealthcare

🎙️ Exciting Podcast Alert: "Identifying The 80% Of Undiagnosed And Misdiagnosed Patients". 🔍 Who should tune in? Clinical trial strategy heads, drug discovery leads, commercial leads, digital/data technology leads in pharma companies. 🔬 What is it about? Join us for a deep dive into Pangaea Data's groundbreaking software platform, fusing clinical guidelines with AI. Discover how it helps pharma companies and healthcare providers pinpoint patients for clinical trials and approved treatments. 💡 Why does it matter? Many medical conditions go undiagnosed, leaving a significant portion of patients untreated. Pangaea Data tackles this challenge head-on, sifting through 500+ million patient records to uncover hidden patients. This not only benefits patients but also streamlines patient recruitment for trials and expands drug markets. Learn about our efforts in cancer cachexia treatment and our collaboration with Microsoft. Tune in and stay ahead in the pharma landscape! https://lnkd.in/gAd6sEbg #Podcast #PharmaInnovation #ClinicalTrials #Citeline 🌟